“Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial”, J. Can. Res. Updates, vol. 2, no. 4, pp.  283–288, Nov. 2013, doi: 10.6000/1929-2279.2013.02.04.6.